Catalyst Event
Lululemon Athletica Inc (LULU) · Earnings Release
From KEDI Global Obesity Care Industry Top 2+ Index (OBCI)
3/17/2026, 12:00:00 AM
Reported Q4 2025 EPS of $5.01, beating estimates but down from $6.14 year-over-year, and issued weak guidance for fiscal year 2026. Analysts forecast full-year 2026 EPS to be $12.10-$12.30, a decline from $13.26 in 2025, with revenue growth slowing to 2-4% forecasted. Weak guidance in the retail sector typically results in significant price corrections, leading to an estimated price impact of ≥10% expected.
Korean Translation
2025년 4분기 주당순이익(EPS)이 5.01달러로 예상치를 상회했으나 전년 동기 대비 감소함. 2026 회계연도 연간 EPS는 12.10~12.30달러, 매출 성장은 2~4%로 둔화될 것으로 전망됨. 소매 부문의 부진한 가이던스는 통상 큰 폭의 주가 조정을 야기하므로 10% 이상의 주가 영향이 예상됨.
Related Recent Events
Novo Nordisk A/S (NVO) · Earnings Release
First quarter 2026 earnings release on May 6, 2026, scheduled.
5/6/2026, 12:00:00 AM
Merck and Co Inc (MRK) · Earnings Release
Merck & Co. is expected to release its Q1 2026 earnings results on or around April 30, 2026, before the market opens. High impact expected as earnings releases often drive price movements exceeding 10%, scheduled.
4/30/2026, 12:00:00 AM
Novartis AG (NVS) · Earnings Release
First quarter 2026 results scheduled for 2026-04-28; high impact expected as a major financial update.
4/28/2026, 12:00:00 AM
Merck and Co Inc (MRK) · Other
The FDA has set a PDUFA target action date of April 28, 2026, for its review of the New Drug Application for doravirine/islatravir, an investigational HIV treatment. Approval typically impacts price by 5-10%, scheduled.
4/28/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Other
Quarterly dividend with an ex-dividend date of April 15, 2026, is scheduled.
4/15/2026, 12:00:00 AM
DICK'S Sporting Goods Inc (DKS) · Other
Quarterly dividend of $1.25 per share, announced on March 11, 2026, with an ex-dividend date of March 27, 2026. This represented a 3.1% increase from the prior dividend.
3/27/2026, 12:00:00 AM